| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 29 May 24 | LRMR Larimar Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 7.07 | 19,000 | 134.33 k | 19,000 |
| 15 May 24 | NLY Annaly Capital Management | Deferred Stock Units Common Stock | Grant | Acquire A | No | No | 0 | 8,583 | 0.00 | 36,282 |
| 16 Feb 24 | LRMR Larimar Therapeutics | Common Stock | Buy | Acquire P | No | No | 8.74 | 57,208 | 500.00 k | 564,798 |
